Tue, Mar 26, 2024
Mankind Pharma's entry into MSCI is possible: After the block deal, the expectation of the stock entering MSCI increased.. The expectation of its inclusion in MSCI's May review increased.. The float is expected to be 25% after the block deal.
More >
Tue, Dec 12, 2023
Big Block Deal in MankindPharma - What are the chances of getting included in MSCI index? Floor price of block deal is ₹ 1785.65/share. If it gets included in MSCI, it will be a big investment? - Know the complete details from Varun...
Mankind Pharma's stock took a nosedive in the early morning trading on Dec 12 after the company announced a massive block deal worth Rs 4,935 crore. This news has investors worried, and the stock is currently down over 4%. In this video, we'll explore the details of this block deal, its impact on Mankind Pharma's future, and what it means for your investment.
Mon, Jul 31, 2023
ManKindPharma straight into Large Cap. Share of Large Cap decreased, Mid Cap increased. Which stocks moved from Mid to Large Cap? See full details in this video
Tue, May 09, 2023
Shares of Mankind Pharma will be listed today. The company has fixed its issue price at Rs 1080 per share. How will be its the listing - at a discount or a premium? What should investors do after listing? Know the opinion of Anil Singhvi on Mankind Pharma's listing.
Wed, Apr 26, 2023
The company has fixed a price band of Rs 1,026-1,080 per share. At the upper end of the price band, the IPO size is estimated at Rs 4,326 crore.
Market wizard Anil Singhvi recommends going long on Mankind Pharma. It is a stock worth having in your portfolio, he adds.
Today is the second day of Mankind Pharma's IPO. The company has fixed its price band at Rs 1026-1080. What is positive and what is negative in Mankind Pharma? What should long-term investors do? Should you apply or avoid this issue?? Know the opinion of Anil Singhvi.
Tue, Apr 25, 2023
Mankind Pharma IPO: The initial share sale of Mankind Pharma opened for subscription on Tuesday, April 25 and it will close on April 27, 2023. Mankind Pharma is the country's fourth-largest pharma company by domestic sales.
Mankind Pharma IPO: Mankind Pharma on Monday said it has raised Rs 1,298 crore from anchor investors ahead of its initial share sale that opens for subscription on April 25.
The 30-share BSE Sensex jumped 401.04 points or 0.67 per cent to reach the 60,000 level and settled for the day at 60,056.10 and the NSE Nifty gained 119.35 points or 0.68 per cent to close at 17,743.40 on Monday.
Mon, Apr 24, 2023
Mankind Pharma is all set to launch an initial share sale on April 25. The company opened its anchor book for institutional investors on April 24. The Mankind Pharma IPO is the fourth primary market offering to hit Dalal Street in 2023 after Divgi TorqTransfer Systems, Global Surfaces and Udayshivakumar Infra.
Mankind Pharma IPO: In the consumer healthcare category, Manforce ranked 1st in the male condom category (market share of 30 per cent), Prega News ranked 1st in the pregnancy test kit category (market share of 80 per cent) and Unwanted-72, ranked 1st in the emergency contraceptive category (market share of 62 per cent).
Mankind Pharma's IPO is entirely an offer for sale (OFS) of more than four crore equity shares by existing shareholders and promoters. At the upper end of the price band, the IPO size is estimated at Rs 4,326 crore.
Wed, Apr 19, 2023
The three-day initial public offering (IPO) will open for subscription during April 25-27, and the bidding for anchor investors will open on April 24, the company announced.
Mankind Pharma IPO: Mankind Pharma’s IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders.
Tue, Apr 18, 2023
Mankind Pharma, the 4th-largest pharmaceutical company in India, is all set to launch its IPO on April 25, 2023. The issue will remain open for subscription till April 27. The initial stake sale is entirely an offer-for-sale by promoters and existing shareholders.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
